JPMorgan Downgrades CME Group (CME) to Neutral, Cuts Price Target to $270

JPMorgan downgraded shares of CME Group (NASDAQ: CME) to a Neutral rating from its previous rating of Over Weight. The firm also cut its price target on the stock from $288 to $270.

For an analyst ratings summary and ratings history on CME Group click here. For more ratings news on CME Group click here.

Shares of CME Group closed at $238.62 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• CME Group plans NHL index-based futures launch for September 28
• Wedbush Downgrades Globant S.A. (GLOB) to Neutral on balanced risk/reward
• CME Group to Launch World's First NHL Futures Based on CME FutureSports Performance Indexes on September 28